Presentation is loading. Please wait.

Presentation is loading. Please wait.

The role of anticoagulation in venous shunts

Similar presentations


Presentation on theme: "The role of anticoagulation in venous shunts"— Presentation transcript:

1 The role of anticoagulation in venous shunts
- a brief overview

2 The use of heparin Activates antithrombin III
Typical regime – loading dose of units/kg followed by 28units/kg/hr < 1yr, 20 units/kg/hr >1 yr and 18 unit/kg/hr in older children Monitoring using APTT (other methods are heparin concentration, anti Factor Xa levels, ACT levels)

3 LMWH Longer t ½ Administered sub-cutaneously
Lower side effects – thrombocytopenia and osteoporosis Enoxaparin 1.5mg/kg 12h (<2mo) and 1mg/kg 12h (> 2mo) Reviparin 150units/kg 12h (< 2 mo) and 100 units/kg 12h (> 2 mo)

4 Warfarin etc Inhibits Vit K dependent clotting factors
Oral loading dose 0.2mg/kg then adjusted using INR Various ranges 2-3 for prophylaxis against TE for valves 3-4.5 for recurrent TE at lower range not tested in kids

5 Aspirin Decreases Platelet aggregation Aspirin+cyclo-oxygenase = TXA2
Effect lasts for 7-10 days 3-5mg/kg/day

6 Dipyridamole Inhibits phospho-diesterase cAMP 2-5mg/kg/day
Adjunct therapy in patients with mechanical valves

7 Pentoxiphylline Enhances RBC flexibility, blood viscosity, platelet aggregation, TNFα 20mg/kg/day Used in PVD with marginal improvement in PBF Kawasaki

8 Glenn and Fontan Use of prosthetic material
Presence of fenestration and R-L shunting Incidence of TE events 5-33% (retrospective, TTE) One partially prospective study showed TEE to be superior to TTE and showed an incidence of thrombus formation in 33% of patients.

9 Coagulopathies in Fontan
Liver derangements Protein C, antithrombin III, Protein S, Plasminogen, Factors II, VII, IX, X, XIII Factor VIII, plasmin-antiplasmin complex, activated partial thromboplastin time, thrombin- antithrombin III complex, D-dimer, Gamma GT, SGOT/PT

10 Risk factors for development of thrombus
Low post op saturations Large fenestration Discordant sized bilateral SVC Atrial dysrhythmia

11 Warfarin for 3mo, 6 mo, 1 yr followed by aspirin
Various strategies No aspirin or warfarin Lifelong Warfarin Lifelong aspirin Warfarin for 3mo, 6 mo, 1 yr followed by aspirin 3-6 mo aspirin

12


Download ppt "The role of anticoagulation in venous shunts"

Similar presentations


Ads by Google